Fundraising Fox
/Companies
Sign in

SentreHeart

Redwood City, US · Delaware corporation · 6 known investors

Find your way into SentreHeart

194 people in our graph share verified history with the SentreHeart team — schools, employers, funds. One of them is your warm intro.

Ahmed Elmouelhiunlockedknows Pam Simons · together at AGA Medical (overlapped)
×2knows the team · via Scimed Life Systems
×5knows the team · via Renovo Rx
×4knows the team · via Cordis

SentreHeart appears to now redirect to AtriCure, Inc., a medical device company. Its content references products such as the cryoXT probe for reducing residual limb pain related to amputation.

BiotechHardwareHealthtechMedical Devices

Founders & leadership

RSRussell Seiber
Russell SeiberExecutive
PSPam Simons
Pam SimonsExecutiveShe brings over 25 years of experience in medical device development, clinical evaluation, and regulatory strategy for Class II and III devices, with expertise spanning pre-clinical through post-market research and customer implementation programs.
GF
Greg FungExecutive
RSRobert Strasser
Robert StrasserVice President Operations2008–2019Robert Strasser is an executive at SentreHeart (now AtriCure), a medical device company that develops products for conditions such as residual limb pain. He has held leadership roles in product development, manufacturing operations, and quality systems, with experience in FDA compliance, M&A due diligence, and product technology transfers.

Board

PYPhil Young
Phil YoungBoard directorSenior Advisor at US Venture Partners
VT
Victor TongBoard director
CTCasey Tansey
Casey TanseyBoard directorGeneral Partner at US Venture Partners
RHRussell Hirsch
Russell HirschBoard directorManaging Director at Prospect Venture Partners
TH
Theodore HuberBoard director
SH
Steven HochbergBoard director
RF
Richard FerrariBoard director
CY
Chen YuBoard director

Investors · 6

Prospect Venture Partnerslisted by Prospect Venture PartnersMenlo Park · $3M – $5Mvia Russell Hirsch · led

How we know: Prospect Venture Partners's portfolio page · Not right? Tell us

US Venture Partnerslisted by US Venture PartnersMenlo Park · $500K – $10Mvia Casey Tansey · board

How we know: US Venture Partners's portfolio page · board seat on SEC Form D · Not right? Tell us

Deerfield Management CompanyreportedNew York

How we know: fiercebiotech.com · Not right? Tell us

U.S. Venture PartnersreportedMinneapolis

How we know: fiercebiotech.com · Not right? Tell us

Vivo CapitalreportedPalo Alto · $10M – $50M

How we know: fiercebiotech.com · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$25M disclosed across 1 round · 2016

▶$25MraisedOct 2016 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Phil YoungDirector
  • Victor TongDirector
  • Casey TanseyDirector
  • Russell HirschDirector
  • Russell SeiberExecutive Officer, Director
  • Theodore HuberDirector
  • Pam SimonsExecutive Officer
  • Greg FungExecutive Officer
  • Steven HochbergDirector
  • Richard FerrariDirector
  • Chen YuDirector
  • Robert StrasserExecutive Officer
Offering amount
$35M
Amount sold
$25M
First sale
Sep 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does SentreHeart do?
SentreHeart appears to now redirect to AtriCure, Inc., a medical device company. Its content references products such as the cryoXT probe for reducing residual limb pain related to amputation.
Who are SentreHeart's investors?
SentreHeart's investors include Decheng Capital, Prospect Venture Partners, US Venture Partners, Deerfield Management Company, U.S. Venture Partners, Vivo Capital.
How much funding has SentreHeart raised?
SentreHeart has disclosed $25M raised across 1 round.
Where is SentreHeart headquartered?
SentreHeart is headquartered in Redwood City, US.